Advances in cell line engineering will make hosts such as yeast and algae desirable alternatives to Chinese hamster ovary (CHO) cells in bioproduction, says Biogen.
GSK says maintaining an unbroken cold chain will be critical as it prepares to rollout malaria vaccine pilot programme.
Daiichi Sankyo will plough ¥15bn ($135m) into three Japanese manufacturing facilities to support its antibody-drug conjugate pipeline.
Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.
Boehringer Ingelheim has broken ground on a €700m stainless steel bioproduction facility set to house 135,000L of mammalian cell culture capacity.
United BioPharma Inc. (UBP), with government backing, has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu Industrial Park, Taiwan.